Xingda Zhang
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 7
- Cancer, Hypoxia, and Metabolism 2
- Cancer, Lipids, and Metabolism 2
-
- RNA modifications and cancer 9
- Epigenetics and DNA Methylation 6
- Cancer-related gene regulation 3
- RNA Research and Splicing 3
-
- Ferroptosis and cancer prognosis 3
- Co-authors
- Shouping XuDa PangHuajiang ChenBo HuJianxi WangFazhi ZangQin WangShipeng Ning
In The Last Decade
Xingda Zhang
18 papers receiving 606 citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Cancer Research 301
- Molecular Biology 450
- Pathology and Forensic Medicine 75
- Pharmacology 52
- Pulmonary and Respiratory Medicine 57
Countries citing papers authored by Xingda Zhang
This map shows the geographic impact of Xingda Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingda Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingda Zhang more than expected).
Fields of papers citing papers by Xingda Zhang
This network shows the impact of papers produced by Xingda Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingda Zhang. The network helps show where Xingda Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xingda Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 15 | |
| 4 | Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancerbreakdown → | 2024 | 55 |
| 5 | 2023 | 0 | |
| 6 | 2022 | 31 | |
| 7 | 2022 | 10 | |
| 8 | 2022 | 14 | |
| 9 | 2022 | 18 | |
| 10 | 2021 | 9 | |
| 11 | 2021 | 1 | |
| 12 | 2020 | 25 | |
| 13 | 2019 | 127 | |
| 14 | 2019 | 182 | |
| 15 | 2019 | 9 | |
| 16 | 2019 | 52 | |
| 17 | 2019 | 48 | |
| 18 | 2019 | 1 | |
| 19 | 1981 | 0 | |
| 20 | 1980 | 11 |
About Xingda Zhang
Xingda Zhang is a scholar working on Cancer Research, Molecular Biology and Pharmaceutical Science, having authored 21 papers that have together received 613 indexed citations. Recurring topics across this work include RNA modifications and cancer (9 papers), Cancer-related molecular mechanisms research (7 papers), Epigenetics and DNA Methylation (6 papers), Ferroptosis and cancer prognosis (3 papers), Cancer-related gene regulation (3 papers), RNA Research and Splicing (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Cancer Research (301 citations), Molecular Biology (450 citations) and Pathology and Forensic Medicine (75 citations). Xingda Zhang has collaborated with scholars based in China and Serbia. Frequent co-authors include Shouping Xu, Da Pang, Huajiang Chen, Bo Hu, Jianxi Wang, Fazhi Zang, Qin Wang, Shipeng Ning, Kun Qiao and Lin Wan. Their work appears in journals such as Chemical Engineering Journal, Desalination and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.